Immununodermatology is the study and treatment of the Immune-Mediated Skin Diseases such as psoriasis. Systemic Lupus Erythematous (SLE), Bullous Pemphigoid (BP) and Pemphigus Vulgaris (PV) are some type of autoimmune diseases, in which our body immune system mistakenly acts against our own healthy cells or tissue or parts of the body. Systemic Lupus Erythematous (SLE) also known as lupus. In this case, most commonly face tissue will affect. The root cause is not entirely clear, it is believed to involve some hormones, environmental and genetic factors. There is no permanent cure for SLE, but corticosteroids, immunosuppressant, hydroxychloroquine and methotrexate will help to reduce the effects. Bullous Pemphigoid is a chronic autoimmune disorder, which will form the blisters (Bullae) at the space between the epidermis and dermis layers of the skin. It comes under the Type II Hypersensitivity. Immunofluorescence study will help to diagnose this disease. Pemphigus Vulgaris is a rare chronic blistering (Oral blisters) skin disease. It also comes under Type II Hypersensitivity.
According to The National Institutes of Health (NIH) from Olmsted country, there are 27 million people suffering from autoimmune skin diseases. In that woman/men ratio was 2.6:1. More than hundred autoimmune diseases are there. Around 50 million Americans have an autoimmune disease. It will affect women 70% more than men.
Related Dermatology Conferences |Dermatology Meetings| Dermatology Events: 12-15th January, 2018 National Doral Miami, USA; 42nd Annual Hawaii Dermatology Seminar, 4-9th February, 2018 Koloa, USA; 5th World Congress of Dermoscopy, 14-16th June, 2018 Thessaloniki, Greece, UK.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
